Maryland’s Department of Health awarded more than $520,000 to 18 groups of fire departments to deploy OneTest, a blood-based multi-cancer early detection (MCED) assay from 20/20 BioLabs. The program funds testing for more than 1,400 firefighters using the company’s assay expected to roll out in April or May. The grant—provided through Maryland’s Professional and Volunteer Firefighter Innovative Cancer Screening Technologies grant program—marks a 225% increase over the prior year’s funded OneTest assays under the same program. The company said it plans to seek U.S. CMS coverage for OneTest for Cancer. The real-world evidence focus—paired with ongoing engagement with FDA and payers—highlights how MCED developers are building reimbursement and adoption pathways beyond purely clinical endpoints.